MD stock reports stronger second quarter earnings

Published on 10/04/2026 at 20:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MD stock was last at USD 25.97 on October 2, 2026, while six analysts set a Hold consensus and a USD 26.60 average target. Q2 adjusted EPS reached USD 0.63.

MD, US58502B1061, Illustration mit AI erstellt.

MD stock was last at USD 25.97 on the NYSE on October 2, 2026, at 4:00 p.m. ET, up 0.82 percent from the prior close. The company behind the ticker, Pediatrix Medical Group, reported second-quarter adjusted EPS of USD 0.63, compared with USD 0.53 a year earlier, according to Yahoo Finance on September 16, 2026.

Revenue growth meets a volume test

Net revenue reached USD 487.8 million in Q2 2026, up 4.0 percent year over year, while adjusted EBITDA rose to USD 76.4 million from USD 73.2 million, Yahoo Finance reported. The improvement came alongside weaker operating volumes: same-unit hospital-based patient services fell 2.8 percent and neonatal intensive care unit days declined 3.2 percent in the quarter.

Pricing, payer mix and acquisitions therefore carried more of the result than patient growth. Same-unit reimbursement-related revenue increased 4.0 percent, while the commercial payer share improved by 135 basis points, according to Yahoo Finance.

Analysts remain close to the market price

Six analysts give Pediatrix an average Hold rating and a USD 26.60 12-month price target, with five Hold ratings and one Buy rating, according to MarketBeat on September 25, 2026. The average target lies 2.43 percent above the October 2 price, leaving the market's view close to the latest quoted level.

Argus lowered its target to USD 27.00 on September 30, 2026, according to Yahoo Finance. That combination of a Hold consensus and a target close to the share price reflects a market weighing improved earnings per share against declining patient volumes and higher operating costs.

MD stock stays below its yearly high

MD was last at USD 25.97 on October 2, 2026, within a 52-week range of USD 15.70 to USD 27.94. Trading volume was 616,412 shares and market capitalization was USD 2.1 billion on the same date, giving investors a current valuation point alongside the Q2 operating figures.